EyePoint Pharmaceuticals

EyePoint Pharmaceuticals, Inc. was founded in 2000 and is headquartered in Massachusetts, USA. It is a specialized biopharmaceutical company dedicated to the development and commercialization of innovative ophthalmic products with high medical needs to help improve the lives of patients with severe eye diseases. The company's preclinical development programs focus on utilizing its core Durasert and Verisome technology platforms to develop drugs for treating age-related macular degeneration, glaucoma, osteoarthritis, and other diseases.